Once-Weekly Byetta
Once-weekly Byetta formulation enters comparator trial.
<Snip>
The 30-week open-label, non-inferiority study will assess whether the
once-weekly long-acting release formulation of the drug is at least as
effective in improving glucose control as twice-daily Byetta.
<Snip>
*Janie*